Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapyTianyu Tang, Tingbo Liang|Signal Transduction and Targeted Therapy|2021Cited by 594
Oncolytic virotherapy: basic principles, recent advances and future directionsDanni Lin, Tingbo Liang|Signal Transduction and Targeted Therapy|2023Cited by 386
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Ghassan K. Abou‐Alfa et al.|The Lancet Oncology|2023Cited by 243
mRNA vaccines in disease prevention and treatmentGang Zhang, Tingbo Liang|Signal Transduction and Targeted Therapy|2023Cited by 217
Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancerQihan Fu, Tingbo Liang|Oncogene|2018Cited by 154